ABSTRACT
Reports suggest that the administration of probiotics could be associated with the potential prevention of cancer through the inhibition of genotoxic metabolites and by reducing the production of bacterial enzymes in the gastrointestinal track (Pool-Zobel et al. 1996, Desrouillères et al. 2015). However, the mechanisms responsible for the inhibition or enhancing of carcinogenic enzymatic activity have not been elucidated (Desrouillères et al. 2015). Current data on the potential role of probiotics in the prevention of cancer focus on in vitro experiments or animal trials; hence caution is needed when extrapolating these outcomes to humans.
